HC
GWPH

Henshaw Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Henshaw Capital’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,208
Closed -$271K – 334
2020
Q2 		$271K Sell
2,208
-953
-30% -$108K 0.02% 235
2020
Q1 		$277K Buy
+3,161
New +$335K 0.03% 202

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Henshaw Capital's GWPH Position: Q3 2020 in Review

Henshaw Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 2,208 shares — an estimated $271K sold.

Henshaw Capital first reported a position in GWPH in Q1 2020 and held it in 2 quarters. The position peaked at $277K in Q1 2020. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

  • Henshaw Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Henshaw Capital sold 2,208 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $271K.
  • Henshaw Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2020 and held it in 2 quarters.
  • Henshaw Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $277K in Q1 2020.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Henshaw Capital's 13F filing for Q3 2020, filed 28 May 2026.